Nitroxide Functionalized Antibiotics Are Promising Eradication Agents against Staphylococcus aureus Biofilms

Area of Science:

• Microbiology
• Infectious Diseases
• Drug Discovery

Background:

• Biofilm-related infections, particularly those caused by Staphylococcus aureus, are difficult to treat with conventional antibiotics.
• The efficacy of nitroxides against Gram-positive bacterial biofilms, like S. aureus, was previously unknown.

Purpose of the Study:

• To investigate the potential of nitroxides in dispersing Staphylococcus aureus biofilms.
• To evaluate the combined efficacy of nitroxides and antibiotics for biofilm eradication.
• To explore the development of dual-acting nitroxide-antibiotic compounds.

Main Methods:

• In vitro testing of nitroxide CTEMPO (4-carboxy-2,2,6,6-tetramethylpiperidin-1-yloxyl) against S. aureus biofilms.
• Co-administration of CTEMPO with ciprofloxacin to assess synergistic effects.
• Development and evaluation of covalently linked nitroxide-antibiotic hybrids.
• Microscopy to visualize biofilm penetration and cellular uptake.

Main Results:

• Nitroxides demonstrated biofilm dispersal activity against Staphylococcus aureus.
• Coadministration of CTEMPO and ciprofloxacin significantly enhanced biofilm eradication.
• Nitroxide-antibiotic hybrids showed improved efficacy and biofilm penetration.
• No observed toxicity to human cells for CTEMPO or the hybrids.

Conclusions:

• Nitroxides are effective in dispersing Gram-positive S. aureus biofilms.
• Dual-acting nitroxide-antibiotic agents represent a promising strategy for treating biofilm-related infections.
• This approach may lead to broad-spectrum therapies for challenging bacterial infections.